These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease. Wilson DE Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of misoprostol on gastric acid secretion in vitro. Qualitative differences from natural prostaglandins. Bertaccini G; Adami M; Coruzzi G Dig Dis Sci; 1988 Oct; 33(10):1265-8. PubMed ID: 3139378 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and gastric antisecretory properties of alpha chain diene derivatives of misoprostol. Collins PW; Gasiecki AF; Jones PH; Bauer RF; Gullikson GW; Woods EM; Bianchi RG J Med Chem; 1986 Jul; 29(7):1195-201. PubMed ID: 3100795 [TBL] [Abstract][Full Text] [Related]
10. Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue. Howden CW; Burget DW; Silletti C; Van Eeden A; Tomkins KB; Hunt RH Aliment Pharmacol Ther; 1987 Aug; 1(4):305-13. PubMed ID: 2979675 [TBL] [Abstract][Full Text] [Related]
11. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors. Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572 [TBL] [Abstract][Full Text] [Related]
12. Effects of misoprostol on gastric acid and mucus secretion in man. Wilson DE; Quadros E; Rajapaksa T; Adams A; Noar M Dig Dis Sci; 1986 Feb; 31(2 Suppl):126S-129S. PubMed ID: 3080283 [TBL] [Abstract][Full Text] [Related]
13. Misoprostol: a prostaglandin E1 analog with antisecretory and cytoprotective properties. Jones JB; Bailey RT DICP; 1989 Apr; 23(4):276-82. PubMed ID: 2499129 [TBL] [Abstract][Full Text] [Related]
14. Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man. Davis GR; Fordtran JS; Dajani EZ Dig Dis Sci; 1988 Mar; 33(3):298-302. PubMed ID: 3125026 [TBL] [Abstract][Full Text] [Related]
15. Perspective on the gastric antisecretory effects of misoprostol in man. Dajani EZ Prostaglandins; 1987; 33 Suppl():68-77. PubMed ID: 3122277 [TBL] [Abstract][Full Text] [Related]
16. Misoprostol and gastroduodenal mucosal protection (cytoprotection). Wilson DE Postgrad Med J; 1988; 64 Suppl 1():7-11. PubMed ID: 3138683 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing. Lam SK; Lau WY; Choi TK; Lai CL; Lok AS; Hui WM; Ng MM; Choi SK Dig Dis Sci; 1986 Feb; 31(2 Suppl):68S-74S. PubMed ID: 3080292 [TBL] [Abstract][Full Text] [Related]
19. 18-cycloalkyl analogues of enisoprost. Collins PW; Gasiecki AF; Perkins WE; Gullikson GW; Jones PH; Bauer RF J Med Chem; 1989 May; 32(5):1001-6. PubMed ID: 2709370 [TBL] [Abstract][Full Text] [Related]
20. Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1. Agrawal NM; Saffouri B; Kruss DM; Callison DA; Dajani EZ Dig Dis Sci; 1985 Nov; 30(11 Suppl):164S-170S. PubMed ID: 3932050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]